Revance Therapeutics Statistics
Total Valuation
BAER has a market cap or net worth of $96.86 million. The enterprise value is $288.03 million.
Important Dates
The next confirmed earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BAER has 54.72 million shares outstanding. The number of shares has increased by 12.49% in one year.
| Current Share Class | 54.72M |
| Shares Outstanding | 54.72M |
| Shares Change (YoY) | +12.49% |
| Shares Change (QoQ) | +1.19% |
| Owned by Insiders (%) | 10.23% |
| Owned by Institutions (%) | 65.74% |
| Float | 36.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.85 |
| Forward PS | 1.01 |
| PB Ratio | 2.46 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.07 |
| P/OCF Ratio | 6.70 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.86, with an EV/FCF ratio of 35.90.
| EV / Earnings | n/a |
| EV / Sales | 2.65 |
| EV / EBITDA | 9.86 |
| EV / EBIT | 26.01 |
| EV / FCF | 35.90 |
Financial Position
The company has a current ratio of 2.19, with a Debt / Equity ratio of 5.43.
| Current Ratio | 2.19 |
| Quick Ratio | 1.55 |
| Debt / Equity | 5.43 |
| Debt / EBITDA | 6.80 |
| Debt / FCF | 26.65 |
| Interest Coverage | 0.47 |
Financial Efficiency
Return on equity (ROE) is -42.60% and return on invested capital (ROIC) is 2.89%.
| Return on Equity (ROE) | -42.60% |
| Return on Assets (ROA) | 2.62% |
| Return on Invested Capital (ROIC) | 2.89% |
| Return on Capital Employed (ROCE) | 4.35% |
| Revenue Per Employee | $569,382 |
| Profits Per Employee | -$192,298 |
| Employee Count | 191 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 97.36 |
Taxes
| Income Tax | -525,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.32% in the last 52 weeks. The beta is 0.16, so BAER's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -47.32% |
| 50-Day Moving Average | 1.76 |
| 200-Day Moving Average | 2.12 |
| Relative Strength Index (RSI) | 47.23 |
| Average Volume (20 Days) | 149,034 |
Short Selling Information
The latest short interest is 693,231, so 1.27% of the outstanding shares have been sold short.
| Short Interest | 693,231 |
| Short Previous Month | 797,144 |
| Short % of Shares Out | 1.27% |
| Short % of Float | 1.93% |
| Short Ratio (days to cover) | 3.15 |
Income Statement
In the last 12 months, BAER had revenue of $108.75 million and -$36.73 million in losses. Loss per share was -$0.71.
| Revenue | 108.75M |
| Gross Profit | 43.28M |
| Operating Income | 11.08M |
| Pretax Income | -53.05M |
| Net Income | -36.73M |
| EBITDA | 29.22M |
| EBIT | 11.08M |
| Loss Per Share | -$0.71 |
Full Income StatementBalance Sheet
The company has $22.65 million in cash and $213.82 million in debt, giving a net cash position of -$191.17 million or -$3.49 per share.
| Cash & Cash Equivalents | 22.65M |
| Total Debt | 213.82M |
| Net Cash | -191.17M |
| Net Cash Per Share | -$3.49 |
| Equity (Book Value) | 39.37M |
| Book Value Per Share | -6.35 |
| Working Capital | 25.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $14.46 million and capital expenditures -$6.44 million, giving a free cash flow of $8.02 million.
| Operating Cash Flow | 14.46M |
| Capital Expenditures | -6.44M |
| Free Cash Flow | 8.02M |
| FCF Per Share | $0.15 |
Full Cash Flow StatementMargins
Gross margin is 39.79%, with operating and profit margins of 10.18% and -10.13%.
| Gross Margin | 39.79% |
| Operating Margin | 10.18% |
| Pretax Margin | -10.61% |
| Profit Margin | -10.13% |
| EBITDA Margin | 26.86% |
| EBIT Margin | 10.18% |
| FCF Margin | 7.38% |
Dividends & Yields
BAER does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.49% |
| Shareholder Yield | -12.49% |
| Earnings Yield | -37.92% |
| FCF Yield | 8.28% |
Analyst Forecast
The average price target for BAER is $5.25, which is 196.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.25 |
| Price Target Difference | 196.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BAER has an Altman Z-Score of -1.23 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.23 |
| Piotroski F-Score | 7 |
